Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K223266
    Manufacturer
    Date Cleared
    2024-01-16

    (449 days)

    Product Code
    Regulation Number
    878.3610
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K123205, K092144

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The HILZO Esophageal Stents are indicated for use in esophageal strictures caused by intrinsic malignant tumors.

    Device Description

    The HILZO Esophageal Stents are partially covered and fully covered, self-expanding tubular prosthesis designed to maintain patency of esophageal strictures. The HILZO Esophageal stents are available loaded on two styles of delivery devices, Over the Wire (OTW) and Through the Scope (TTS). The OTW delivery devices are 14Fr and the TTS is 10.5Fr to enable delivery through the working channel of an endoscope. The stents are made of Nitinol wire and are designed to prevent stent migration due to peristaltic motion and tumor in-growth. The stents are available in a variety models, diameters and lengths.

    AI/ML Overview

    The document provided is a 510(k) Premarket Notification from the FDA for a medical device: the Hilzo Esophageal Stents. This type of submission is for demonstrating "substantial equivalence" to a legally marketed predicate device, not for establishing novel safety and effectiveness through clinical trials or performance studies involving complex metrics like those for AI/ML devices (e.g., sensitivity, specificity, clinical workflow improvement).

    Therefore, the vast majority of the requested information regarding acceptance criteria, study design, ground truth establishment, expert adjudication, MRMC studies, and training set details are not applicable to this particular document. This document focuses on demonstrating that the new device is as safe and effective as a previously cleared device, primarily through bench testing comparing physical and mechanical properties, and biocompatibility.

    Here's what can be extracted and what cannot:

    1. A table of acceptance criteria and the reported device performance

    The document provides a comparative table where "acceptance criteria" are implicitly defined by similarity to the predicate device's performance, often with an explicit acceptance range (e.g., "fell within the +/- 5% difference acceptance criteria").

    FeatureAcceptance Criteria (compared to Niti-S Esophageal K080782)Reported HILZO Esophageal Stent Performance Range / ValueReported Niti-S Esophageal Performance Range / Value
    Regulatory NumberSame878.3610878.3610
    Product CodeSameESWESW
    Indication for UseSameFor esophageal strictures caused by intrinsic and/or extrinsic malignant tumorsFor esophageal strictures caused by intrinsic and/or extrinsic malignant tumors
    Principle of OperationSimilar/Same (TTS and OTW models for HILZO, OTW for predicate)TTS and OTW models availableOTW
    BiocompatibilityBiocompatible per ISO 10993Biocompatible per ISO 10993 (found to be)Biocompatible per ISO 10993
    Single UseYesYesYes
    SterilityEtoEtoEto
    Stent materialNitinolNitinolNitinol
    Covering materialSimilar (biocompatibility and mechanical testing support equivalence)Silicone/PTFESilicone
    Stent diameter (mm)Similar (compression & expansion testing support differences)18-20 mm16-20 mm
    Stent total length (mm)Similar (compression & expansion testing support differences; context of other cleared stents)60-150 mm60-120 mm
    Stent headSimilar flaring stent head designSilicone covered and uncovered flaring stent head design with/without removal string (lasso)Silicon covered and uncovered flaring stent head design with/without removal string (lasso)
    Delivery DiameterSimilar (deployment testing and tensile strength demonstrate performance)OTW - 14 Fr, 16 Fr; TTS - 10.5 FrOTW - 16 Fr and 20 Fr
    MR StatusMR ConditionalMR ConditionalMR Conditional
    Expansion ForceAll results fell within ±5% differenceRange: 0.442-0.537 kgf (Avg.)Range: 0.439-0.543 kgf (Avg.)
    Compression ForceAll results fell within ±5% differenceRange: 3.073-3.925 kgf (Avg.)Range: 3.093-3.914 kgf (Avg.)

    2. Sample size used for the test set and the data provenance

    The document mentions "extensive biocompatibility data" and various "Non-Clinical Performance Testing" types (shelf-life, expansion force, compression force, etc.). However, it does not specify sample sizes for these tests. The data provenance would be that of the manufacturer's internal testing. It's retrospective in the sense that the tests were completed before the submission. No country of origin for specific test data is provided, but the manufacturer is Thoracent, Inc. in Huntington, NY, USA.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This is not applicable. For this type of device (a physical medical implant), "ground truth" is established through engineering and biological performance standards, not expert medical opinion on a data set. The device is evaluated on its physical and mechanical properties and biocompatibility.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable. There is no expert adjudication process for bench testing results in the way there would be for image interpretation in an AI/ML study.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This is a physical medical device (stent), not an AI/ML diagnostic or assistive software. MRMC studies are used for evaluating the impact of AI on human reader performance for diagnostic tasks.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This is a physical medical device, not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    For this device, "ground truth" is established through:

    • Engineering specifications and standards: For mechanical properties like expansion and compression force, dimensions, tensile strength, kink resistance.
    • Biocompatibility standards (e.S. ISO 10993): For biological safety, ensuring the materials are not toxic or harmful to the body.
    • Sterilization validation: Ensuring the device can be terminally sterilized.
    • MR safety standards: To determine if the device is safe for patients undergoing MRI.

    8. The sample size for the training set

    Not applicable. This is a physical medical device, not an AI/ML model that requires a training set.

    9. How the ground truth for the training set was established

    Not applicable. As above, no training set for an AI/ML model exists for this device.

    Ask a Question

    Ask a specific question about this device

    K Number
    K140472
    Manufacturer
    Date Cleared
    2014-10-17

    (234 days)

    Product Code
    Regulation Number
    878.3720
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K092144, K093003

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The BONASTENT® Tracheal/Bronchial Stent System is indicated for the treatment of tracheobronchial strictures caused by malignant neoplasms.

    Device Description

    The BONASTENT® Tracheal/Bronchial (BTB) is a self-expanding tubular prosthesis designed to maintain patency of tracheobronchial strictures caused by malignant tumors. The stent is made of Nitinol wire and is weaved using a hook & cross wire construction; a silicon membrane covers the stent and is designed to prevent stent migration. Stent sizes range in diameter from 10mm to 20mm and in length from 50mm to 80mm.

    The BONASTENT® Tracheal/Bronchial is available on two types of delivery devices. The Y-Shape Handle Delivery Device is used for stents with an outer diameter of 10Fr and less. The I-Shape Handle Delivery Device which is used for stents with an outer diameter larger than 10F.

    AI/ML Overview

    The provided text describes the 510(k) Summary for the BONASTENT® Tracheal/Bronchial device. This document focuses on demonstrating substantial equivalence to a predicate device rather than presenting a study with explicit acceptance criteria and device performance metrics in the typical sense of a clinical trial. However, it does outline performance characteristics compared to its predicate.

    Here's an analysis based on the information provided, framed to address your request for acceptance criteria and supporting studies where possible, while noting limitations due to the nature of a 510(k) summary for a stent:

    1. Table of Acceptance Criteria and Reported Device Performance

    For this specific device (a tracheal/bronchial stent), the "acceptance criteria" are implicitly defined by demonstrating equivalence to a legally marketed predicate device (AERO Tracheobronchial Stent System). The performance data supplied are comparative benchmarks rather than direct acceptance criteria against a defined threshold.

    Performance MetricAcceptance Criteria (Implicit: Comparable to Predicate)Reported Device Performance (BONASTENT® Tracheal/Bronchial)Predicate Device Performance (AERO Tracheobronchial)
    Intended UseTreatment of tracheobronchial strictures caused by malignant neoplasms.Treatment of tracheobronchial strictures caused by malignant neoplasms.Treatment of tracheobronchial strictures caused by malignant neoplasms.
    Stent MaterialNitinolNitinolNitinol
    Covering Material(Compared for differences)SiliconePolyurethane membrane
    Stent Diameter (mm)10, 12, 14, 16, 18, 2010, 12, 14, 16, 18, 2010, 12, 14, 16, 18, 20
    Stent Length (mm)20-8020-8020-80
    Delivery Diameter(Compared for differences)8F - 12F16F and 22F
    Deployment Time(Reference, as predicate unknown)Non-aged stents average 16.97 sec; Aged stents 16.4 secUnknown
    Expansion Force (10x20 stent)Comparable to 0.390 lbs. (AERO)0.367 lbs.0.390 lbs.
    Expansion Force (20x80 stent)Comparable to 0.763 lbs. (AERO)0.748 lbs.0.763 lbs.
    Compression Force (10x20 stent)Comparable to 0.519 lbs. (AERO)0.517 lbs.0.519 lbs.
    Compression Force (20x80 stent)Comparable to 1.026 lbs. (AERO)1.026 lbs.1.026 lbs.
    Corrosion Resistance (in simulated gastric fluid)Comparable to predicate (which is unknown, but "Resistant" is the claim)Resistant to corrosion for a duration equivalent to 3 yearsUnknown
    BiocompatibilityDemonstratedPassed various tests (Cytotoxicity, Maximization sensitization, Acute systemic toxicity, Rabbit Pyrogen Study, Intracutaneous reactivity, Bacterial reverse mutation assay, Intramuscular implantation study)Passed (implied previous results for reference devices)
    Deployment TestingAccuracy and repeatability of the delivery system validated.All components, subassemblies, and/or full devices met required specifications.N/A (Internal test)
    Dimensional TestingReproducibility of stent length and diameter after deployment verified.All components, subassemblies, and/or full devices met required specifications.N/A (Internal test)
    Tensile Strength TestsPerformed for deployment system components with bonds/welds.All components, subassemblies, and/or full devices met required specifications.N/A (Internal test)

    2. Sample Size Used for the Test Set and Data Provenance

    The "test set" in this context refers to the samples used in bench testing.

    • Sample Size: Not explicitly stated for each test, but implied to be sufficient for the validation and comparative testing performed on the stent models (e.g., 10x20 and 20x80 stents) and deployment systems.
    • Data Provenance: The studies are described as "Bench Testing" and "in-vitro tests," meaning they were conducted in a laboratory environment. There is no information regarding country of origin for the data or whether it's retrospective or prospective.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    Not applicable for this type of submission. This document pertains to bench testing and substantial equivalence, not a clinical study requiring expert ground truth for interpretation of medical data.

    4. Adjudication Method for the Test Set

    Not applicable. Adjudication methods like 2+1 or 3+1 refer to clinical data review, typically by medical experts for diagnoses or outcomes, which is not part of this bench testing summary.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This is a medical device (stent) submission, not an AI diagnostic or assistive device.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This is a medical device (stent) submission, not an algorithm.

    7. The Type of Ground Truth Used

    For the bench tests, the "ground truth" is defined by the physical properties measured against established engineering and material standards, or by direct comparison to the predicate device's measured performance. For instance, expansion force measurements are compared directly to the predicate's measurements. Biocompatibility relies on standardized tests.

    8. The Sample Size for the Training Set

    Not applicable. There is no "training set" as this is not a machine learning or AI device.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1